About Hemodiaz
Hemodiaz is a Healthcare company based in Chevy Chase (United States) founded in 2012. It manufactures and sells medical devices, supplies, and treatments online. It operates on a B2C and D2C model. The company has 1 employees. Its Indian entity Hemodiaz Life Sciences Private Limited reported revenue of ₹59.98 Cr. Hemodiaz offers products and services including Nebulizer Kit, ECG Machine, Oxygen Concentrator, and Facial Steam Vaporizer. Its focus areas include Medical Devices, Home Medical Supplies, Oxygen Concentrators and Personal Care. Its competitors include Tomorrow Health, Medinas and Cohealo; 3 of its 3 listed competitors have raised funding.
Company details
Hemodiaz Lifesciences is a provider of medical equipment, including nebulizers, ECG machines, and oxygen concentrators. It operates through an online platform with free shipping for orders above a certain value, serving customers in India. Based in New Delhi, the company focuses on home healthcare and hospital supplies, ensuring quality products for families and healthcare users. It has been established since 1998 and emphasizes reliable customer support.
- Headquarters Chevy Chase, United States
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website hemodiaz.com
- Social Facebook
- Legal Name Hemodiaz Life Sciences Private Limited
- Date of Incorporation 24 Jul, 1998
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹59.98 Cr
FY 2025 · +57% YoY
- Indian entity net profit₹37.3 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹2.16 Cr
FY 2025 · 4% margin
- Employee Count1
Associated legal entities of Hemodiaz
Hemodiaz operates through Hemodiaz Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hemodiaz Life Sciences Private Limited CIN U33111DL1998PTC095173 | Active | 24 Jul 1998 | New Delhi, Delhi | ₹60.0 Cr | 1 | 3 | View details |
Products & Services of Hemodiaz
Hemodiaz offers a comprehensive portfolio of products and services, including Nebulizer Kit, ECG Machine, Oxygen Concentrator, and Facial Steam Vaporizer.
Portable device for delivering medication via inhalation.
Device for monitoring heart electrical activity accurately.
Machine that provides supplemental oxygen for patients.
Tool for relieving cough and cold symptoms effectively.
Board of directors of Hemodiaz Life Sciences Private Limited (Hemodiaz)
Hemodiaz Life Sciences Private Limited is the primary company behind Hemodiaz. The board of Hemodiaz Life Sciences Private Limited currently have 3 directors; the longest-serving is Vipin Dhawan, appointed in 2025. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vipin Dhawan DIN 00477405 | Director | 30 May 2025 | 1 yr 4 mo | Hemodiaz Life Sciences Private Limited |
| Shilpa Kapoor DIN 03607067 | Director | 08 Aug 2025 | 1 yr 2 mo | Hemodiaz Life Sciences Private Limited |
| Ishita Dhawan DIN 11291353 | Director | 10 Sep 2025 | 1 yr 1 mo | Hemodiaz Life Sciences Private Limited |
Financials of Hemodiaz
Figures of Hemodiaz Life Sciences Private Limited, the primary company behind Hemodiaz, for FY 2025. Revenue was ₹59.98 Cr (+57% year on year). Net profit was ₹37.3 Lakh (1% margin). EBITDA was ₹2.16 Cr (4% margin). Revenue has grown at a compounded annual rate of -3% over three years and +6% over five years.
- ₹59.98 CrRevenue · FY 2025 · +57% YoY
- ₹37.3 LakhNet profit · 1% margin
- ₹2.16 CrEBITDA · 4% margin
- ₹1.06 CrPaid-up capital
- 1Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hemodiaz Life Sciences Private Limited are on its company page.
Detailed financial statements for Hemodiaz
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Hemodiaz
Hemodiaz has 3 listed competitors in our database, 3 of them funded. They include Tomorrow Health, Medinas and Cohealo.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tomorrowhealth.com | 2018 | New York, United States | $92.5M | 126 | Provider of an online store for healthcare products | |
| medinas.com | 2017 | Berkeley, United States | $7.07M | Provider of marketplace platform to buy and sell medical supplies and equipment | ||
| cohealo.com | 2012 | Boston, United States | $15.12M | 17 | Medical equipment is rented out to hospitals via a platform. |
Detailed competitors of Hemodiaz
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Hemodiaz (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hemodiaz
Complete news archive for Hemodiaz
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemodiaz
Hemodiaz was founded in 2012.
Hemodiaz is headquartered in Chevy Chase, United States. It is registered at Chevy Chase, Maryland, United States.
Hemodiaz has 1 employees.
The primary company behind Hemodiaz, Hemodiaz Life Sciences Private Limited, reported revenue of ₹59.98 Cr for FY 2025, up 57% year on year.
Hemodiaz Lifesciences is a provider of medical equipment, including nebulizers, ECG machines, and oxygen concentrators. It operates through an online platform with free shipping for orders above a certain value, serving customers in India. Based in New Delhi, the company focuses on home healthcare and hospital supplies, ensuring quality products for families and healthcare users. It has been established since 1998 and emphasizes reliable customer support.
Hemodiaz's top competitors include Tomorrow Health, Medinas and Cohealo.
Hemodiaz offers Nebulizer Kit, ECG Machine, Oxygen Concentrator, and Facial Steam Vaporizer.
Hemodiaz operates through Hemodiaz Life Sciences Private Limited.
The legal entities of Hemodiaz currently have 3 directors, including Vipin Dhawan, Ishita Dhawan, Shilpa Kapoor.